MARKER THERAPEUTICS INC's ticker is MRKR and the CUSIP is 57055L107. A total of 67 filers reported holding MARKER THERAPEUTICS INC in Q4 2021. The put-call ratio across all filers is 0.18 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2022 | $98,766 | +43.1% | 374,964 | +100.0% | 0.00% | – |
Q3 2022 | $69,000 | +11.3% | 187,482 | 0.0% | 0.00% | – |
Q2 2022 | $62,000 | -25.3% | 187,482 | -1.1% | 0.00% | – |
Q1 2022 | $83,000 | -55.6% | 189,482 | -3.6% | 0.00% | – |
Q4 2021 | $187,000 | -43.7% | 196,651 | 0.0% | 0.00% | – |
Q3 2021 | $332,000 | -38.3% | 196,651 | +2.0% | 0.00% | – |
Q2 2021 | $538,000 | -58.3% | 192,751 | -66.5% | 0.00% | – |
Q1 2021 | $1,291,000 | +64.7% | 576,225 | +6.6% | 0.00% | – |
Q4 2020 | $784,000 | -7.1% | 540,604 | -3.9% | 0.00% | – |
Q3 2020 | $844,000 | -23.0% | 562,503 | +6.2% | 0.00% | – |
Q2 2020 | $1,096,000 | -0.6% | 529,671 | -8.8% | 0.00% | – |
Q1 2020 | $1,103,000 | -32.8% | 580,677 | +1.9% | 0.00% | – |
Q4 2019 | $1,642,000 | -41.0% | 569,995 | +4.7% | 0.00% | – |
Q3 2019 | $2,782,000 | -29.4% | 544,503 | +9.4% | 0.00% | – |
Q2 2019 | $3,941,000 | +2715.0% | 497,578 | +2247.1% | 0.00% | – |
Q1 2019 | $140,000 | +18.6% | 21,200 | 0.0% | 0.00% | – |
Q4 2018 | $118,000 | – | 21,200 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Aisling Capital Management LP | 3,142,857 | $1,163,000 | 0.77% |
NEA Management Company, LLC | 10,714,285 | $3,951,000 | 0.20% |
ACT CAPITAL MANAGEMENT, LLC | 354,400 | $131,000 | 0.18% |
Long Focus Capital Management, LLC | 1,461,000 | $539,000 | 0.05% |
AR ASSET MANAGEMENT INC | 279,000 | $103,000 | 0.03% |
MATRIX ASSET ADVISORS INC/NY | 400,000 | $148,000 | 0.02% |
Mandatum Life Insurance Co Ltd | 99,000 | $37,000 | 0.01% |
WealthTrust Axiom LLC | 22,700 | $8,000 | 0.00% |
Riggs Asset Managment Co. Inc. | 18,500 | $7,000 | 0.00% |
NEVILLE RODIE & SHAW INC | 60,202 | $22,000 | 0.00% |